A Comprehensive Review on Synergistic Polyherbal Strategies for Parkinson’s Disease: Advances in Formulation, Standardization, and Artificial Intelligence-integrated Phytopharmaceutical Development

Paeonol as a Multi‐Target Therapy for Neurological Disorders: Mechanistic Insights Into Neuroprotection

Neurological disorders are a major global health challenge in the current era, and they need new therapeutic treatments.

Complementary Mitochondrial and α‐Synuclein Signatures Refine Biological Stratification of Parkinson's Disease

We read with interest the Viewpoint by Percetti and colleagues proposing the concept of a biologically de fi ned mitochondrial subtype of Parkinson ’ s disease (PD) ( “ MitoPD

New high-throughput screening study may open up for future Parkinson's disease therapy

Design of bifunctional pyridinophane ligands as Mn 2+ MRI agents for diagnostic imaging of Alzheimer's disease

Alzheimer's disease (AD) is a progressive neurodegenerative disorder whose prevalence is rising with the aging of the global population. Among the proposed pathological hallmarks, the amyloid-beta (Aβ) peptide aggregates and...

Sciadonic Acid Ameliorates Cognitive Impairment in APP/PS1 Mice with Concomitant Modulation of Gut Microbiota and Brain Metabolism

Alzheimer's disease (AD) is a progressive neurodegenerative disorder with complex pathogenesis. Sciadonic acid (SCA), a fatty acid from Torreya grandis oil, possesses antiinflammatory and antioxidant properties, but its effects on...

Multi‐omics identification of haptoglobin as a novel target for increased Alzheimer's disease risk associated with obesity through inhibiting the phagocytosis of Aβ by disease‐associated microglia

Obesity may increase Alzheimer's disease (AD) risk, yet the underlying mechanisms remain unclear.